Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Oct, 2019 | Pages:
110 | Publisher: Grand View Research
Industry: Medical Devices | Report Format: Electronic (PDF)
The Europe diabetes devices market size is expected to reach 8.7 billion by 2026, according to a new report by Grand View research, Inc. registering a CAGR of 4.0% over the forecast period. The size of the market is justified by the contribution from developed European economies such as Germany, U.K., France, and Italy. The prevalence of diabetes is rising amongst all ages in the European countries, mainly due to the unhealthy lifestyle, obesity, overweight, and physical inactivity. According to the International Diabetes Federation (IDF), around 66.0 million people in Europe are suffering from diabetes and this number is expected to increase to around 81.0 million by 2045. Thus, rising diabetes population base in this region is anticipated to be a major driver for the Europe diabetes devices market. Additionally, the region is expected to witness high growth rate during the forecast period due to the continuous efforts towards diabetes control by the government and healthcare organizations such as the IDF. These organizations provide required expertise and support diabetes awareness campaigns through a network of stakeholders and partners. Also, increasing health care funding in the region is anticipated to propel the market's growth. Moreover, rising geriatric population is also anticipated to propel the market growth over the forecast period. In 2018, nearly one fifth of the Europe's population was over 65 years age which is further fueling the diabetes device market. According to the United Nation report on World Population Aging, older population in Europe is projected to constitute 35.0% of total population by 2050. Furthermore, leading manufacturers are focusing on technological innovations and advanced product development to gain remarkable share in the market. Further key findings from the report suggest: • Germany held the largest market share owing to favorable reimbursement policies, local presence of key market players, and supportive government initiatives. • In the self-monitoring and diagnostic devices segment, digital glucose monitors held the largest market size of 1.2 billion in 2018 and is growing at a CAGR of over 4.6% during the forecast period. • Insulin pens held the largest market share in 2018 and the segment is projected to grow at a CAGR of 3.7% over the forecast period. The growth in this segment is attributed to ease of use and the ability to deliver accurate dosage. • Insulin pumps segment is expected to grow during the forecast period. The segment is primarily driven by its advantage such as need of fewer injections to deliver insulin. • Some of the prominent players include in Europe diabetes devices market are Eli Lilly and Company, Medtronic, Inc., Novo Nordisk A/S, Sanofi, Becton, Dickinson and Company, F. Hoffmann-La Roche, Ltd., B.Braun Melsungen AG, Ypsomed Holding AG, Abbott Laboratories and others.
Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Gvr's Internal Database
1.2.3 Secondary Sources
1.2.4 Primary Research
1.2.5 Details of Primary Research
1.2.5.1 Data for Primary Interviews in Europe
1.3 Information or Data Analysis
1.3.1 DATA ANALYSIS MODELS
1.4 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market lineage outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 User Perspective Analysis by Stage
3.3.1 Consumer Behavior Analysis
3.3.2 Market Influencer Analysis
3.4 List of Key End Users, by region, by product, by country
3.5 Regulatory Framework
3.5.1 Reimbursement Framework
3.5.2 Standards & Compliances?
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Growing prevalence of obesity
3.6.1.2 Increasing number of diabetes patient
3.6.1.3 Technological innovation and product advancements
3.6.1.4 Untapped opportunities in the developing economies
3.7 Market Restraint Analysis
3.7.1 Stringent government rules and regulation
3.7.2 Industry Challenges
3.8 Europe Diabetes Devices: Market Analysis Tools
3.8.1. Industry Analysis - Porter's
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Substitution Threat
3.8.1.4 Threat from new entrant (low)
3.8.1.5 Competitive rivalry
3.8.2 PESTEL Analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social Landscape
3.8.2.4 Technology Landscape
3.8.2.5 Legal Landscape
3.9 Major Deals & Strategic Alliances Analysis
3.9.1 Joint Ventures
3.9.2 Mergers & Acquisitions
3.9.3 Licensing & Partnership
3.9.4 Technology Collaborations
3.9.5 Strategic Divestments
3.10 Market Entry Strategies
Chapter 4 Europe Diabetes Devices Market: Product Estimates & Trend Analysis
4.1 Diabetes Devices: Product Analysis
4.2 Monitoring and Diagnostic Devices
4.2.1 Monitoring and diagnostic devices market, by type, 2015 - 2026 (USD Million)
4.2.2 Digital glucose monitor
4.2.2.1 Digital glucose monitor Market, 2015 - 2026 (USD Million)
4.2.3 Analog Glucose Monitor
4.2.3.1 Analog glucose monitor market, 2015 - 2026 (USD Million)
4.2.4 Continuous glucose monitor
4.2.4.1 Continuous glucose monitor Market, 2015 - 2026 (USD Million)
4.3 Insulin Delivery Devices
4.3.1 Insulin delivery devices market, by type, 2015 - 2026 (USD Million)
4.3.2 Pens
4.3.2.1 Pens market, 2015 - 2026 (USD Million)
4.3.3 Pumps
4.3.3.1 Pumps market, 2015 - 2026 (USD Million)
4.3.4 Syringes
4.3.4.1 Syringes market, 2015 - 2026 (USD Million)
4.3.5 Jet Injector
4.3.5.1 Jet Injector market, 2015 - 2026 (USD Million)
Chapter 5 Europe Diabetes Devices: Regional Estimates & Trend Analysis
5.1 Europe
5.2 Europe diabetes devices market, 2015 - 2026 (USD Million)
5.2.1 U.K.
5.2.1.1 U.K. diabetes devices market, 2015 - 2026 (USD Million)
5.2.2 Germany
5.2.2.1 Germany diabetes devices market, 2015 - 2026 (USD Million)
5.2.3 France
5.2.3.1 France diabetes devices market, 2015 - 2026 (USD Million)
5.2.4 Italy
5.2.4.1 Italy diabetes devices market, 2015 - 2026 (USD Million)
5.2.5 Spain
5.2.5.1 Spain diabetes devices market, 2015 - 2026 (USD Million)
5.2.6 Poland
5.2.6.1 Poland diabetes devices market, 2015 - 2026 (USD Million)
5.2.7 Switzerland
5.2.7.1 Switzerland diabetes devices market, 2015 - 2026 (USD Million)
5.2.8 Austria
5.2.8.1 Austria diabetes devices market, 2015 - 2026 (USD Million)
Chapter 6 Company Profiles
6.1 Novo Nordisk A/S
6.1.1 Company overview
6.1.2 Financial performance
6.1.3 Product benchmarking
6.1.4 Strategic initiatives
6.2 Abbott Laboratories
6.2.1 Company overview
6.2.2 Financial performance
6.2.3 Product benchmarking
6.2.4 Strategic initiatives
6.3 Eli Lilly and Company
6.3.1 Company overview
6.3.2 Financial performance
6.3.3 Product benchmarking
6.3.4 Strategic initiatives
6.4 Medtronic, Inc.
6.4.1 Company overview
6.4.2 Financial performance
6.4.3 Product benchmarking
6.4.4 Strategic initiatives
6.5 Sanofi
6.5.1 Company overview
6.5.2 Financial performance
6.5.3 Product benchmarking
6.5.4 Strategic initiatives
6.6 Becton, Dickinson and Company
6.6.1 Company overview
6.6.2 Financial performance
6.6.3 Product benchmarking
6.6.4 Strategic initiatives
6.7 F Hoffmann-La Roche, Ltd.
6.7.1 Company overview
6.7.2 Financial performance
6.7.3 Product benchmarking
6.7.4 Strategic initiatives
6.8 B. Braun Melsungen AG
6.8.1 Company overview
6.8.2 Financial performance
6.8.3 Product benchmarking
6.8.4 Strategic initiatives
6.9 Ypsomed Holding AG
6.9.1 Company overview
6.9.2 Financial performance
6.9.3 Product benchmarking
6.9.4 Strategic initiatives
List of Tables Table 1 List of abbreviation Table 2 Europe diabetes devices market, by Region, 2015 - 2026 (USD Million) Table 3 Europe diabetes devices market, by Product, 2015 - 2026 (USD Million) Table 4 U.K. diabetes devices market Revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million) Table 5 U.K. diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million) Table 6 Germany diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million) Table 7 Germany. diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million) Table 8 France diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million) Table 9 France diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million) Table 10 Italy diabetes Devices Market Revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million) Table 11 Italy diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million) Table 12 Spain diabetes Devices Market Revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million) Table 13 Spain diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million) Table 14 Poland diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million) Table 15 Poland diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million) Table 16 Switzerland diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million) Table 17 Switzerland diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million) Table 18 Austria diabetes devices market revenue, by monitoring and diagnostic devices, 2015 - 2026 (USD Million) Table 19 Austria diabetes delivery devices market revenue, by insulin delivery devices, 2015 - 2026 (USD Million)
List of Figures Fig. 1 Market research process Fig. 2 Data triangulation techniques Fig. 3 Primary research pattern Fig. 4 Primary interviews in Europe Fig. 5 Market research approaches Fig. 6 Value-chain-based sizing & forecasting Fig. 7 QFD modeling for market share assessment Fig. 8 Market formulation & validation Fig. 9 Europe diabetes devices market, 2018 Fig. 10 Europe diabetes devices segmentation Fig. 11 Europe diabetes devices market trends Fig. 12 Europe diabetes devices: market driver impact Fig. 13 Europe diabetes devices: market restraint impact Fig. 14 Penetration & growth prospect mapping Fig. 15 Europe diabetes devices market - pestle analysis Fig. 16 Industry analysis - porter's Fig. 17 Europe diabetes devices competitive landscape: Market position analysis (Based on products, regional presence) Fig. 18 Europe diabetes devices market: Product outlook key takeaways Fig. 19 Europe diabetes devices: Product movement analysis Fig. 20 Europe Diabetes Devices market: Material outlook key takeaways Fig. 21 Others market, 2015 - 2026 (USD million) Fig. 22 Regional marketplace, 2015 - 2026 (USD million) Fig. 23 Europe diabetes devices market, 2015 - 2026 (USD million) Fig. 24 U.K. diabetes devices market, 2015 - 2026 (USD million) Fig. 25 Germany diabetes devices market, 2015 - 2026 (USD million) Fig. 26 France diabetes devices market, 2015 - 2026 (USD million) Fig. 27 Italy diabetes devices market, 2015 - 2026 (USD million) Fig. 28 Spain diabetes devices market, 2015 - 2026 (USD million) Fig. 29 Poland diabetes devices market, 2015 - 2026 (USD million) Fig. 31 Switzerland diabetes devices market, 2015 - 2026 (USD million) Fig. 32 Austria diabetes devices market, 2015 - 2026 (USD million)
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
